Skip to main content
. 2011 Jun 30;43(2):89–95. doi: 10.4143/crt.2011.43.2.89

Table 2.

Comparison of clinicopathologic characteristics according to duration of DRFS for relapsed patients (n=122)

graphic file with name crt-43-89-i002.jpg

DRFS, distant relapse free survival; SD, standard deviation; HR, hormone receptor; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; TNBC, triple negative breast cancer; IDC, invasive ductal carcinoma; PFSR, progression free survival rate; OSR, overall survival rate. a)Extensive bone metastases,≥10 bones involvement with or without bone destruction soft tissue formation, b)Skeletal events, associated with bone metastases as pain, fracture, and limit of motion.